EPI in Canadian Breast Cancer Biomarker Collaboration | GenomeWeb
NEW YORK (GenomeWeb News) – Expression Pathology will collaborate with the Tom Baker Cancer Centre in Alberta, Canada, to identify breast cancer metastasis biomarkers, EPI said today.
The project is being funded with CAD$300,000 ($288,000) from the Alberta Cancer Board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.